Applications published 11 July 2007
A highly porous, fast-disintegrating solid dosage form and its way of manufacturing comprising the preparation of a powder and a freeze-drying step
Pantec 1804764*
Low oil emulsion compsns for delivering taxoids and other insoluble drugs
SO Pharmaceuticals 1804765*
Purified phospholipid-non-steroidal anti-inflammatory drug associated compsns and methods for preparing and using same
The Board of Regents, The University of Texas System 1804766*
Biocompatible drug delivery apparatus and methods
Theracoat 1804767*
Pharmaceutical compsns comprising fenofibrate and atorvastatin
Lifecycle Pharma 1804768*
Pharmaceutical compsn comprising fenofibrate and atorvastatin
LifeCycle Pharma 1804769*
Lubricious compounds for biomedical applications using hydrophilic polymers
Foster Corp 1804770*
Compsns for controlled delivery of pharmaceutically active compounds
Idexx Laboratories 1804771*
Granules comprising a NSAID and a sugar alcohol made by melt extrusion
Reckitt Benckiser Healthcare (UK) 1804772*
Loadable polyphosphazene-comprising particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
Polyzenix 1804773*
Disintegrating buccal tablets
BASF 1804774*
Methods for making and using composites, polymer scaffolds, and composite scaffolds
Cytori Therapeutics 1804776*
Pharmaceutical compsn comprising diclofenac
Novartis; Novartis-Pharma 1804777*
Use of a beta-3 agonist for treating complaints of the prostate and the lower urogenital tract
Boehringer Ingelheim International 1804778*
Use of an MTOR inhibitor in treatment of uterine leiomyoma
Wyeth 1804779*
Medium-chain length fatty alcohols as stimulators of haematopoiesis
Prometic Biosciences 1804780*
Novel cyclic and acyclic propenones for treating CNS disorders
Merz Pharma 1804781*
Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4"-trifluoromethylphenyl)-amide for treating inflammatory bowel disease
Aventis Pharmaceuticals 1804782*
Method of using adapalene in acne maintenance therapy
Galderma Research & Development 1804783*
The treatment of inflammatory bowel disease
Sosei R&D 1804784*
Diaryl ureas as CB1 antagonists
Neurogen 1804785*
Substituted N-aryl-9-oxo-9H-fluoerene-1-carboxamides and analogues as activators of caspases and inducers of apoptosis
Cytovia 1804786*
Flavonoid compsn for treating oral diseases
Unigen Pharmaceuticals 1804787*
Detection and analysis of ophthalmically-relevant fluorescent molecules
Sirion Therapeutics 1804788*
Method of treating human pre eclampsia employing resibufagenin
The Administrators of the Tulane Educational Fund 1804789*
Use of inhibitors of JUN N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
Alcon 1804790*
Tetrahydro pyridinyl pyrazole cannabinoid modulators
Janssen Pharmaceutica 1804791*
Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-CoA-desaturase
Xenon Pharmaceuticals 1804792*
2-(aryl)azacyclylmethyl carboxylates, sulphonates, phosphonates, phosphinates and heterocycles as S1P receptor agonists
Merck & Co 1804793*
Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease
Merck 1804794*
Enantiomeric compsns of cicletanine, alone and in combination with other agents, for the treatment of disease
Cornett, Glen 1804795*
Amino substituted aryloxybenzyl-piperidine derivatives
H Lundbeck 1804796*
Use of a pyridine compound for the preparation of a medicament for the treatment of skin lesions
Tanabe Seiyaku 1804797*
Methods for the treatment of substance abuse and addiction
Merck 1804798*
Heterocyclic derivatives and their use as stearoyl-CoA desturase inhibitors
Xenon Pharmaceuticals 1804799*
Use of 4-(4-methylpiperazin-1-ylmethyl)-N-Y4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl-benzamide to inhibit the tyrosine kinase receptor C-FMS
Medvet Science 1804800*
Methods of treating vascular injuries
Biogen Idec 1804801*
Combination comprising ZD6474 and an imatinib
AstraZeneca 1804802*
Compounds and compsns as hedgehog pathway modulators
IRM; The Scripps Research Institute 1804803*
Loxapine analogues and methods of use thereof
Hypnion 1804804*
Use of aromatase inhibitors for the treatment of ectopic pregnancy
Wayne State University; Mount Sinai hospital 1804805*
Methods and compsns for enhancing degradation of nuclear receptor transcription factors and uses thereof
AndroScience 1804806*
Coadministration of tigecycline and digoxin
Wyeth 1804807*
Pyridoxal-5-phopshate and stent for the treatment and prevention of atherosclerosis and restenosis
Mediure International 1804808*
Combined treatment with bortezomib and an epidermal growth factor receptor kinase inhibitor
Piperdi, Bilal, Simonds-Sinon Regional Cancer Center 1804809*
Methods using glycosaminoglycans for the treatment of kidney disease
Keryx Biopharmaceuticals 1804810*
Methods and compsns for treating flaviviruses, pestiviruses and hepaciviruses
Idenix (Cayman); Centre National de la Recherche Scientifique 1804811*
Fluorinated pyrroloy2-3-Dâ€Âpyrimidine nucelosides for the treatment of RNA-dependant RNA viral infection
Merck 1804812*
Formulations and methods for treatment of inflammatory diseases
Valentis 1804813*
Multi-purpose bio-material compsn
Lally, Thomas 1804814*
Antidiabetic extract isolated from rauvolfia vomtoria and citrus Aurantium, and methods of using same
Campbell-Tofte, Joan 1804815*
Combination therapy comprising cloretazine
Vion Pharmaceuticals 1804816*
Methods for promoting wound healing
Advanced Viral Research 1804817*
Methods and compsns for use in angiogenesis inhibitors in the prevention and/or control of epilepsy
Henry Ford Health System 1804818*
Use of aromatase inhibitors for endometrial thinning in preparation for surgical procedures on the endometrial cavity and uterus
Wayne State University; Mount Sinai Hospital 1804820*
Vasoactive intestinal polypeptide pharmaceuticals
Forbes Medi-Tech (Research) 1804820*
HCV NS3-NS4A protease inhibition
Vertex Pharmaceuticals 1804821*
HCV vaccine for chronic HCV patients
Intercell 1804822*
Novel cyclosporin analogues and their pharmaceutical uses
AMR Technology 1804823*
FSH and FSH receptor modulator compsns and methods for inhibiting osteoclastic bone resorption and bone loss in osteoporosis
Mount Sinai School of Medicine of New York University 1804824*
Treatment of neurological deficits in the striatum or substantia nigra pars compacta
Ethicon 1804825*
Treatment of neurological deficits in the striatum or substanta nigra pars compacta
Ethicon 1804826*
Methods for treating cancer
Allergan 1804827*
The use of protease or a protease inhibitor for the manufacture of medicaments
Yeda Research and Development 1804828*
T-cadherin antigen arrays and uses thereof
Cytos Biotechnology 1804829*
Cancer-testis antigens
The Ludwig Institute for Cancer Research; Cornell Research Foundation; Memorial Sloan-Kettering Cancer Centre 1804830*
Listeria-based and LLO-based vaccines
The Trustees of the University of Pennsylvania 1804831*
Methods and compsns for needleless delivery of macromolecules
Trinity Biosystems 1804832*
Staphylococcal immunogenic compsns
GlaxoSmithKline Biologicals; The University of Sheffield; Biosynexus 1804833*
Immunogenic bacterial vesicles with outer membrane proteins
Novartis Vaccines and Diagnostics 1804834*
Multimeric constructs
Genzyme 1804835*
Methods of diagnosing and treating complications of pregnancy
Beth Israel Deaconess Medical Centre 1804836*
Combined treatment with radiation and an epidermal growth factor receptor kinase inhibitor
Harai, Paul; Chinnaiyan, Prakash; Huang, Shymin 1804837*
Drug conjugates of long chain fatty acid or ester moieties as protein binding prodrugs
Drug Discovery Laboratory; Cockbain, Julian 1804838*
Improved expression of factor IX in gene therapy vectors
St Jude Children's Research Hospital 1804839*
Sweat reducing cosmetic preparation
Beiersdorf 1804840*